SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced two upcoming investor events:

More here:
Assembly Bio Announces Upcoming Investor Events

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh